November 3, 2005
Tarceva Approved for Pancreatic Cancer
The Food and Drug Administration approved a lung cancer medication Wednesday as a new treatment for pancreatic cancer.
Tarceva does not cure pancreatic tumors and helps patients live only a little longer, according to a study of more than 500 patients that led to the drug's approval. But while Tarceva may be only a "small step forward," it also could be a "harbinger of things to come," says Robert Wolff, an associate professor at Houston's M.D. Anderson Cancer Center who was involved in the study. (USA Today)
